Ipswich Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.18M Buy
75,012
+3,187
+4% +$220K 1.25% 25
2025
Q1
$4.99M Buy
71,825
+2,545
+4% +$177K 1.24% 28
2024
Q4
$5.96M Sell
69,280
-1,267
-2% -$109K 1.43% 22
2024
Q3
$8.4M Sell
70,547
-570
-0.8% -$67.9K 1.95% 14
2024
Q2
$10.2M Sell
71,117
-1,291
-2% -$184K 2.38% 8
2024
Q1
$9.3M Sell
72,408
-1,968
-3% -$253K 2.18% 6
2023
Q4
$7.69M Sell
74,376
-7,394
-9% -$765K 1.95% 9
2023
Q3
$7.44M Sell
81,770
-10,440
-11% -$949K 2.03% 8
2023
Q2
$7.46M Sell
92,210
-4,884
-5% -$395K 1.96% 9
2023
Q1
$7.73M Sell
97,094
-392
-0.4% -$31.2K 2.11% 8
2022
Q4
$6.6M Sell
97,486
-3,756
-4% -$254K 1.89% 10
2022
Q3
$5.04M Sell
101,242
-1,732
-2% -$86.3K 1.61% 15
2022
Q2
$5.74M Sell
102,974
-1,786
-2% -$99.5K 1.65% 13
2022
Q1
$5.82M Buy
104,760
+1,420
+1% +$78.8K 1.44% 17
2021
Q4
$5.79M Sell
103,340
-200
-0.2% -$11.2K 1.35% 17
2021
Q3
$4.97M Sell
103,540
-1,488
-1% -$71.4K 1.27% 19
2021
Q2
$4.4M Buy
105,028
+12
+0% +$503 1.12% 22
2021
Q1
$3.54M Buy
105,016
+2,820
+3% +$95.1K 1% 33
2020
Q4
$3.57M Buy
102,196
+360
+0.4% +$12.6K 1.07% 32
2020
Q3
$3.54M Buy
101,836
+65,978
+184% +$2.29M 1.13% 30
2020
Q2
$1.17M Buy
35,858
+19,000
+113% +$622K 0.4% 63
2020
Q1
$507K Sell
16,858
-2
-0% -$60 0.2% 103
2019
Q4
$488K Hold
16,860
0.14% 123
2019
Q3
$436K Sell
16,860
-200
-1% -$5.17K 0.14% 126
2019
Q2
$435K Buy
17,060
+100
+0.6% +$2.55K 0.14% 127
2019
Q1
$444K Sell
16,960
-210
-1% -$5.5K 0.15% 120
2018
Q4
$396K Buy
17,170
+5,900
+52% +$136K 0.15% 115
2018
Q3
$266K Buy
+11,270
New +$266K 0.09% 145
2016
Q2
Sell
-4,000
Closed -$110K 264
2016
Q1
$110K Buy
+4,000
New +$110K 0.05% 166